Including FOSS software is so wild in this conversation that it's ridiculous. You mean creating a product as a loss leader to get people into an ecosystem, farm social capital, create a sales funnel, or get free labor from the community to provide QA? The creation and release of software is NOWHERE NEAR the same category as "doing actual real scientific research" that it just smells of incredibly bad faith argumentation.
Economic analysis? Another intelligence product that requires essentially no staff, no actual R&D, no equipment besides computers? Brother, you have to be kidding me.
The hardware thing is just companies evolving to a shared standard.
Do you have even a little bit of a clue how hard it is to do good pharmacological research? Toxicological? Biological? Chemical? Physical? You have mentioned intelligence products with 0 investment cost and 0 risk of failure.
This is perhaps one of the most fart-sniffing tech-centric perspectives I have ever been exposed to. Go read some actual research by actual scientists and come back when you can tell me why, for instance, Eli Lilley would ever make their data or internal R&D public.
Jonas Salk did it. He is an extremely rare exception, and his incentive was public health. Notice that his incentive was markedly not financial.
Market entities with a financial incentive, whose entire business model and success is predicated on their unique R&D results, have 0 incentive to release research to the public.
Economic analysis? Another intelligence product that requires essentially no staff, no actual R&D, no equipment besides computers? Brother, you have to be kidding me.
The hardware thing is just companies evolving to a shared standard.
Do you have even a little bit of a clue how hard it is to do good pharmacological research? Toxicological? Biological? Chemical? Physical? You have mentioned intelligence products with 0 investment cost and 0 risk of failure.
This is perhaps one of the most fart-sniffing tech-centric perspectives I have ever been exposed to. Go read some actual research by actual scientists and come back when you can tell me why, for instance, Eli Lilley would ever make their data or internal R&D public.
Jonas Salk did it. He is an extremely rare exception, and his incentive was public health. Notice that his incentive was markedly not financial.
Market entities with a financial incentive, whose entire business model and success is predicated on their unique R&D results, have 0 incentive to release research to the public.